In all cases, it exceeded 85%.
High Performance Liquid Chromatography (HPLC)
The apparatus consists of the Beckman (Altex) programmable system with the 9420 programmer microprocessing unit, two 1lOA pumps, a Hitachi 100-40 multiwave length detector and a Kipp & Zonen B D 41 chart recorder.
All reverse phase chromatography is carried out on Beckman ultrasphere ODS columns.
Several buffer systems, gradient profiles and separation conditions were employed before determining the optional set of conditions for our requirements.
The conditions most commonly used consist of a sodium phosphate buffer (SOmM, pH 2.7) containing .05% triethylamine (cf 17) as solvent A, and 100% acetonitrite (CH3 CN) as solvent B. The flow rate is typically 1 ml/min.
The most commonly employed gradient program is depicted in Fig. 1 . Percentage of acetonitrite is raised to 20% in 2 minutes, left constant for 2 minutes, then raised to 45% in 25 minutes, where it remains for another 2 minutes, before returning to 5% in 2 minutes for a total duration of 33 min./run. b This gradient profile allows eluti n of most of the peptides under study.
However, it can readily be altered in the interest of better separation or speed when the peptides being run are known to elute at specific points along the gradient.
Other variations include changing the sodium phosphate buffer strength between 30 to 50 mM. While higher concentrations produce sharper resolution, lower concentrations lead to less interference with some of the RIA's, especially when the tissue contains relatively low levels of peptides, and the fractions are not highly diluted.
We have also employed potassium phosphate (30-50mM) rather than sodium phosphate buffer as solvent A, when opiate binding 'assays were to be conducted in the absence of sodium.
In all cases, the buffers and solvents are prepared according to Rivier (17), using HPLC-grade materials, and filtering aqueous buffers through 0.45 Millipore filter. All HPLC procedures are carried out at room temperature.
Pure peptide standards (0.5 -1.0 nmole) are injected in lo-40 p liter volume, and monitored at 210 nmeter.
The effluent from the Hitachi monitor is collected in 0.5ml fractions and subjected to radioimmunoassay. Radioactive peptides (10,000 -200,000 DPM) are similarly treated and the fractions counted with beta or gamma scintillation counters as appropriate.
Tissue extracts prepared as described above are also injected in a 10-40 111 volume, monitored at 210 nmeter and the fractions evaporated either in a vacuum oven (room temperature) or in a Savant evaporator, resuspended in the appropriate buffer at the proper dilution, and subjected to RIA. Peak 2: a-MSH. Gra lents begins at right of figure, at 5% acetonitrite and rises in stages, to 45% acetonitrite. lnmole of peptide injected. Note close correspondence at low concentrations, and non-parallelism at high concentration, suggesting N-terminus directed low affinity population of antibodies.
The absence of a C-terminus-directed population is indicated by the lack of inhibition of binding when the C-terminus tetrapeptide (B-E27_31) is employed.
Thus, B-El-27 shows the same shown but confirmed). 
Multiplicity of B-E Immunoreactivity in Pituitary and Brain
Zakarian and Smyth (10) have reported that B-E is stored in both active and inactive forms. They described the existence of 'I true" B-E or B-LPH61_glwhich they had termed the C fragment, a C' fragment or B-El-27, and the N-acetylated forms of these two peptides.
All were not available when we began our experiments which has prevented us and others from using them as standards. We have since obtained these compo und s , and used them to identify the immunoreactive peaks, as described below. The characteristics of the B-E RIA employed are displayed in Fig. 2 . The separation of the multiple forms of B-E is shown in Fig. 3 .
When rat neurointermediate/posterior lobes are extracted, applied to HPLC using our standard gradient then subjected to RIA the pattern in Figure  4 emerges. Immunoreactive profile of rat anterior lobe following HPLC. Extracts were first sieved on Biogel P go*
The B-E-sized material was then applied to HPLC as describe in the text. Peaks are identified as B-E and a small amount of N-acetyl B-E. 
